Cargando…

Frontal encephalopathy related to hyperinflammation in COVID-19

Detalles Bibliográficos
Autores principales:	Cani, Ilaria, Barone, Valentina, D’Angelo, Roberto, Pisani, Lara, Allegri, Vincenzo, Spinardi, Luca, Malpassi, Paola, Fasano, Luca, Rinaldi, Rita, Fanti, Stefano, Cortelli, Pietro, Guarino, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353824/ https://www.ncbi.nlm.nih.gov/pubmed/32654063 http://dx.doi.org/10.1007/s00415-020-10057-5

Ejemplares similares

Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
por: Pensato, Umberto, et al.
Publicado: (2021)

Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine
por: Baldelli, Luca, et al.
Publicado: (2021)

Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy
por: Pensato, Umberto, et al.
Publicado: (2021)

Akinetic mutism in COVID-19-related encephalopathy: A cytokine-mediated maladaptive sickness behavioral response?
por: Pensato, Umberto, et al.
Publicado: (2021)

Clinicoradiological Profile and Functional Outcome of Acute Cerebral Venous Thrombosis: A Hospital-Based Cohort Study
por: Foschi, Matteo, et al.
Publicado: (2021)

Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)

Anti-LGI1 encephalitis following COVID-19 vaccination: a case series
por: Asioli, Gian Maria, et al.
Publicado: (2022)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment
por: Muccioli, Lorenzo, et al.
Publicado: (2020)

Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
por: Muccioli, Lorenzo, et al.
Publicado: (2020)

Case report: Bilateral double beta peak activity is influenced by stimulation, levodopa concentrations, and motor tasks, in a Parkinson’s disease patient on chronic deep brain stimulation
por: Giannini, Giulia, et al.
Publicado: (2023)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
Publicado: (2020)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
por: -, -
Publicado: (2020)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?
por: Versace, Viviana, et al.
Publicado: (2021)

Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome
por: Cozzolino, Domenico, et al.
Publicado: (2023)

Current Concepts of Hyperinflammation in Chronic Granulomatous Disease
por: Rieber, Nikolaus, et al.
Publicado: (2012)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
por: Chen, Jiezhong, et al.
Publicado: (2020)

Hyperinflammation with COVID-19: The key to patient deterioration?()()
por: Haigh, Kathryn, et al.
Publicado: (2020)

Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
por: Taha, Sara Ibrahim, et al.
Publicado: (2022)

Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022)

Fostering experimental and computational synergy to modulate hyperinflammation
por: Potapov, Ilya, et al.
Publicado: (2022)

In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation
por: Li, Xiaoyu, et al.
Publicado: (2023)

Tracheostomy is associated with increased survival in Multiple System Atrophy patients with stridor
por: Giannini, Giulia, et al.
Publicado: (2022)

Hyperinflammation bei SARS-CoV-2-Infektion
Publicado: (2020)

Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
por: Tanner, Tamara, et al.
Publicado: (2020)

IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)

Attenuating hyperinflammation in COVID-19: A change in paradigm?
por: Molnar, Zsolt, et al.
Publicado: (2020)

ACEi reduces hypertension-induced hyperinflammation in COVID-19
por: Lim, Gregory B.
Publicado: (2021)

Clinical Application of Diffusion Tensor Imaging for a Brachial Plexus Injury
por: Vara, Giulio, et al.
Publicado: (2022)

Tract metastasis from previously unknown malignant pleural mesothelioma: a case report
por: Bartalena, Tommaso, et al.
Publicado: (2009)

Frontal assessment battery: A tool for screening minimal hepatic encephalopathy?
por: de Souza, Karina Zamprogno, et al.
Publicado: (2016)

Pseudomonas aeruginosa biofilm is a potent inducer of phagocyte hyperinflammation
por: Ciszek-Lenda, Marta, et al.
Publicado: (2019)

A nanotrap improves survival in severe sepsis by attenuating hyperinflammation
por: Shi, Changying, et al.
Publicado: (2020)

COVID‐19: lambda interferon against viral load and hyperinflammation
por: Andreakos, Evangelos, et al.
Publicado: (2020)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation
por: Gioia, Marco Di, et al.
Publicado: (2019)

Concurrent Immune Suppression and Hyperinflammation in Patients With Community-Acquired Pneumonia
por: Brands, Xanthe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5vi9cps3fb6udgqoeedc70bfek